News

Solar, biotech, and health insurance stocks are rising on Friday: here's why

A fter a whirlwind week of economic data, stocks are taking a chill pill on Friday, ending off the week on a low note. The ...

RBC Capital Reaffirms Their Buy Rating on PTC Therapeutics (PTCT)

Detailed price information for Ptc Therapeutics (PTCT-Q) from The Globe and Mail including charting and trades.

Barclays Sticks to Their Hold Rating for PTC Therapeutics (PTCT)

Detailed price information for Ptc Therapeutics (PTCT-Q) from The Globe and Mail including charting and trades.
Medical Marketing & Media23h

Rx Rundown: Bayer, BlinkRx, Pfizer and more

AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...